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IN THE INTERVAL since a trial of ortho-
topic liver transplantation was resumed at 
the University of Colorado, an attempt has 
been made to treat 14 patients. The most 
important conclusion that has emerged from 
this experience is that survival for at least 
13 months can be obtained in humans. How-
ever, the present communication will focus 
attention upon several special problems of 
orthotopic liver transplantation including 
the high incidence of vascular thrombosis 
that has been encountered, the necessity for 
retransplantation in some cases if life is to 
continue, some miscellaneous technical com-
plications, the development of metastases in 
patients whose original disease was hepa-
toma, and the occurrence and character of 
indolent late rejection. 
MORTALITY 
Five of the 14 patients are still alive 7, 6, 
5, P~I and l~ months postoperatively. The 
deaths occurred ~I 1, 4, 35, 60, 105, 133, 
186, and 400 days after transplantation. The 
causes of failure will be returned to below. 
VASCULAR COMPLICATIONS 
Regional De-arterialization-In previous 
publications1,2. selective thrombosis of the 
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right hepatic artery was described. In 4 of 
the first 6 cases in the series, this accident 
occurred from 2 to 104 days after operation 
and led to regional hepatic gangrene, sep-
ticemia, and immediate or delayed death. A 
fifth patient amongst the first 6 also had 
this complication, but recovered only to die 
more than a year later from other causes. In 
the latter case, it was found at autopsy that 
the left hepatic artery had also thrombosed, 
probably at a later time. Nevertheless, the 
dearterialized liver had provided good func-
tion for many months. 
The explanation for lobar arterial throm-
bosis is probably a complex one. However, 
there is some evidence2 that distortion of 
the right hepatic artery, which may result 
from failure to fix the homograft in its nor-
mal anatomic position, can be a contribut-
ing factor. Segmental liver infarction has 
not been seen in the subsequent cases in 
which the ligaments of the liver were re-
attached to the companion structures in the 
recipient. 
Acute Total De-arterialization-This ca-
lamity has cost the lives of 2 pediatric pa-
tients. One was a 12 month old 5.7 kg child 
with biliary atresia who received an ortho-
topic homograft that had been minimally 
damaged by ischemia. The donor was 21 
months old and weighed 10.5 kg. The new 
liver was barely accomodated in the he-
patic fossa. After revascularization the 
homograft immediately elaborated large 
quantities of bile. However, within a half 
hour, the arterial anastomosis clotted, ne-
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Fig. I.-Course of a child whose homograft hepatic artery thrombosed a few hours 
postoperatively. Diagnostic serum enzyme changes did not develop until 24 hours after 
the vascular accident. Note the evidence of hemolysis. 
cessitating its excision and reconstruction. 
She was returned to the intensive care unit 
awake and with a systolic blood pressure of 
150 mmHg. Five hours later the blood pres-
sure suddenly fell to 80 mmHg and she be-
came somnolent. 
Reclotting of the hepatic artery was sus-
pected but the serum transaminases then 
and at 6 to 12 hour intervals were only 
slightly elevated for the next 24 hours (Fig-
ure 1). The SCOT then abruptly rose to 
more than 10,000 units. A liver scan showed 
almost no isotope concentration in the area 
of the liver. The child died 2Jf days later. 
Hemolysis which began on the second post-
operative day became so overwhelming that 
the hematocrit fell to zero during the last 
day of life (Figure 1); concomitantly there 
was rapidly deepening jaundice. At autopsy 
the liver had a thrombosed artery, an in-
tact portal vein and massive but incomplete 
necrosis. 
In another child, aged 8 years, a double 
arterial supply to the diseased liver was 
found at the time of hepatectomy, the larger 
vessel originating from the superior mesen-
teric artery and supplying the right lobe. It 
was thought that the caliber of the mesen-
teric branch was too small to permit ade-
quate perfusion of the homograft hepatic 
artery. Consequently, the celiac axis of the 
transplanted liver was attached to the side 
of the recipient upper abdominal aorta 
( Figure 2A). The revascularized homograft 
became pink and secreted bile. There was 
some difficulty in closing the incision since 
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Fig. 2.-Anomalous hepatic ar-
terial supply encountered in 2 
patients. In each, the larger of 
2 hepatic arteries originated from 
the superior mesenteric artery. 
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(A) Attempted vascular recon-
struction. Note the compression 
of the homograft arterial blood 
supply by the caudate lobe of 
the oversized homograft. This was 
not detected in one case and 
resulted in early death. RiQht liepatic a. 
fyom sup. mese.nte.ric (}. 
the liver, which was taken from a 27.7 kg 
10 year old donor, was too large for the 15.3 
kg recipient. 
Two hours after returning to the recov-
ery room, the patient developed refractory 
shock and lapsed into coma; she died 5 
hours later. At autopsy, the liver was cyano-
tic and enormously swollen. The vascular 
anastomoses were patent. However, the ar-
terial pedicle was under considerable ten-
(B) In the second patient, the 
graft hepatiC artery was eventu-
ally anastomosed to the superior 
mesenteric branch. However, the 
child died of portal vein throm-
bosis to which the size disparity 
of the portal vessels probably 
contributed. 
sion and was displaced inferiorly by a 
protruding caudate lobe. Apparently, the un-
satisfactory disposition of the vessel had 
been aggravated by closure of the abdom-
inal incision (Figure 2A). 
Portal Vein Thrombosis-The cause of 
failure in the foregoing case was not fully 
appreciated until exactly the same arterial 
anomaly was encountered in the next pa-
tient in the series, in which the other con-
dition of an oversized organ was also pres-
ent. The recipient was a 26 month old child 
with biliary atresia who was given the liver 
of a 5 year old donor. As in the previous 
case, the homograft celiac axis was anas-
tomosed to the recipient aorta. It was dem-
onstrated that when the abdominal incision 
was approximated, the hepatic artery was 
pinched off (Figure 2A). Consequently, the 
patient was given 3 mg/kg intravenous hep-
arin and the homograft hepatic artery was 
transected and anastomosed to the recipient 
mesenteric branch (Figure 2B). N eutraliz-
ing protamine sulfate was not given. The 
homograft appeared to have a good arterial 
supply, although the gallbladder did not 
bleed as vigorously as usual. 
After operation, the child woke promptly. 
Within 8 hours, the serum bilirubin had 
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fallen from 16 to 0.8 mg%. Twenty hours 
after completion of the transplantation she 
developed acute abdominal distention and 
massive gastrointestinal bleeding. Death 
followed 90 minutes later. At autopsy the 
arterial anastomosis was patent, but the 
portal vein was completely occluded with 
fresh thrombus. In this case, the recipient 
portal vein had been much smaller than 
that of the homograft (Figure 2B). 
Adrenal Infarction-In removing the re-
cipient liver and the enclosed segment of 
vena cava, the right adrenal vein must be 
sacrificed. The adrenal gland underwent 
venous infarction in a 24 year old woman, 
whose indication for the orthotopic proce-
dure was hepatoma; she did not have portal 
hypertension before transplantation nor any 
indication of abnormal venous collaterals. 
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Fig. 3.-The course of a patient with biliary atresia after orthotopic liver transplantation. 
Jaundice recurred within 2 months of discontinuing treatment with horse ALG. Treatment 
with rabbit ALG was ultimately instituted. 
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An emergency right adrenalectomy was 
performed. She recovered but died 5 weeks 
later of Pseudomonas pneumonitis. In one of 
our earlier cases, not included in this report, 
right adrenal necrosis also occurred but 
without secondary hemorrhage; the compli-
cation was discovered at autopsy one week 
postoperatively. 
SIZE DISCREPANCY 
Ideally, liver homografts should be ob-
tained from donors of approximately the 
same size and age as the recipients. How-
ever, the extent to which disparities are ac-
ceptable is an important practical question 
which has not yet been fully answered. In 
the last 14 cases there have been 6 in which 
the donor and recipient sizes were equiva-
lent, one in which the donor was consider-
ably smaller (body weight ratio 2:3), and 7 
in which the donor weighed much more than 
the recipient (ratios 1.5-2.3:1). All of the 
patients in the first 2 categories lived for at 
least one month after operation. Three of 
the 7 in the third group had early death 
from the hepatic arterial or portal occlu-
sions cited in the preceding section. The 
significance of these findings was obscured 
by the fact that anomalies of the recipient 
hepatic arteries complicated the operations 
in 2 of the 3 technically unsuccessful cases. 
Nevertheless, the way in which the excessive 
size of the homo grafts contributed to at 
least 2 of the failures was emphasized ear-
lier. 
It is also clear, however, that the use of 
oversized homo grafts is not incompatible 
with success. One of the patients who is 
alive after 6 months is a 39 kg girl who re-
ceived the liver of an 82 kg man. Two in-
fants who weighed 11 and 14 kg at the time 
of operation are alive with the livers of 25 
and 32 kg donors. 
COAGULATION ABNORMALITIES 
It is unlikely that either the lobar or 
the main arterial or portal thromboses men-
tioned above had an entirely mechanical 
basis. It has been recognized for several 
years3,4 that there are unique risks of both 
bleeding and clotting after liver transplan-
tation, that the danger of a hemorrhagic dia-
thesis is greatest during the intraoperative 
period, and that this hazard may often be 
succeeded by that of hypercoagulability 
particularly if a minimally damaged organ 
is used which is capable of rapid correction 
of deficient clotting factors. Thrombosis of 
part or all of the homograft arterial supply 
has also been seen in centers other than our 
own.5,6 
The trepidation with which intraopera-
tive anticoagulation with heparin might be 
prophylactically undertaken is understand-
able, especially when recipient hepatec-
tomy has been made difficult and bloody by 
pre-existing portal hypertension. Neverthe-
less, this step should probably be consid-
ered in selected cases in which homograft 
procurement and storage have been carried 
out under optimum conditions. 
LATE REJECTION 
In all the cases in this series, azathioprine, 
prednisone, and horse antilymphocyte glo-
bulin (ALe) were begun just before or at 
the time of transplantation. The first 2 
agents were continued indefinitely in vari-
able doses. The ALe was ultimately discon-
tinued in all but one of the long surviving 
patients either because the end of an arbi-
trary 4 month period of administration had 
been reached or because there was evidence 
of increasing sensitization to the foreign 
protein. There were no instances of irrevers-
ible acute rejection during the interval of 
triple drug therapy. However, an indolent 
but moderately severe deterioration of liver 
function characteristically appeared after 
the discontinuance of ALe. We have had 
6 patients who have been observed after 
stopping ALe. In 5, jaundice recurred with-
in one to 8 weeks, necessitating drastic re-
visions in therapy. 
Examples are shown in Figures 3 and 4. 
The first recipient, a 2 year old child with 
SGOT-
SGPT ------
( I.u.) 
ALKALINE 
PHOSPHATASE 
(I.U.) 
TOTAL PROTEIN-
ALBUMIN - - - ---
Y GLOBULIN ----.- .. 
(mg per 100 mil 
BILIRUBIN 
(mg per 100 mil 
TOTAL-
CONJUGATED -----
AZATHIOPRINE 
(mg) 
PREDNISONE 
(mg) 
HORSE ~ 
ALG RABBIT IIIIIil!!IIIIII 
221 
• FIRST ORTHOTOPIC I TRANSPLANTATION 
TIME IN DAYS 
Fig. 4.-An example of orthotopic retransplantation of the liver. Uncontrolled rejection 
of the first homograft occurred shortly after horse ALG had been stopped because of 
severe reactions at the injection sites. Desensitization to horse protein was attempted. A 
second liver was eventually transplanted. 
biliary atresia, had no overt rejection for the 
first 6 months, but then became jaundiced 
within 8 weeks after the cessation of ALG 
injections (Figure 3). The prednisone dose 
was increased without effect. A course of 
rabbit ALG was subsequently started with 
a gradual but incomplete return of the 
functional abnormalities toward normal. 
The other patient (Figure 4) had equine 
ALG discontinued 19 days after operation 
for biliary atresia because of severe local re-
actions. Progressive rejection promptly de-
veloped, eventually necessitating retrans-
plantation. Rabbit ALG was used on the 
second occasion. The experience with these 
cases, as well as that after cadaveric renal 
transplantation, has convinced us of the ne-
cessity to devise improved protocols for 
ALG administration. Several possible alter-
native approaches are discussed elsewhere 
in the proceedings of this meeting.7 
METASTATIC DISEASE 
Four patients in the series had hepa-
tomas. One died of pneumonitis after 5 
weeks and had no residual tumor. The child 
who survived for more than 13 months, 
eventually died from widespread metas-
tases within the abdomen, thorax, cranial 
vault, and soft tissues of the extremities. 
Another patient, a 43 year old man, has 
x-ray findings suggestive of small metas-
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tases in the right lung, 5 months postopera-
tively. There is no evidence of recurrent 
tumor in a 16 year old girl after 6 months 
observation. 
RETRANsPLANTATION 
The patient was 23 months old at the 
time of the first operation on May 26, 1968. 
The donor, aged 3)f years, had total con-
formity with the recipient of the 9 HLA 
groups then being measured by Dr. Paul 
Terasaki of Los Angeles. Initial hepatic 
function was excellent until the horse ALG 
was stopped prematurely because of intense 
swelling and erythema at the injection sites. 
Rejection began 3 days later and could not 
be reversed (Figure 4). The child became 
progressively more ill with high fevers, per-
sistent tachycardia of 160-220/minute, and 
generalized edema. 
On July 31, 1968 the first homograft was 
removed and replaced with the liver of a 
25 kg, 7 year old donor; the histocompati-
bility match was less favorable than with 
the original transplantation in that there 
were mismatches in the Terasaki groups 6 
and 7. The excised rejecting homograft was 
enormous (weight 880 grams) and had 
many superficially located infarcts. Histo-
logically there were thromboses in some of 
the peripheral arterial and portal venous 
radicles as well as moderately heavy mono-
nuclear cell infiltration which was concen-
trated mostly in the portal tracts. 
Liver chemistries were promptly restored 
to normal (Figure 4). The postoperative 
course was very stormy, primarily because 
of the disproportionate size of the trans-
plant which made both breathing and 
alimentation difficult; the slight additional 
abdominal distention caused by eating pre-
cipitated respiratory crises. In spite of these 
early problems and a subsequent diffuse 
pneumonitis of unknown etiology, the child 
survived and is in good condition with good 
liver function 6 weeks later. He is being 
treated with very small doses of azathio-
prine, 0.5 mg/kg per day prednisone, and 
rabbit ALG. 
The 5 patients who were surviving at the 
time of the meeting are still alive OF~ months 
later. 
REFERENCES 
1. Starzl, T. E., Groth, C. G., Brettschneider, 
L., Moon, J. B., Fulginiti, V. A., Cotton, E. K. 
and Porter, K. A.: Extended survival in 3 cases 
of orthotopic homotransplantation of the human 
liver. Surgery, 1968, 63:549. 
2. Starzl, T. E., Groth, C. G., Brettschneider, 
L., Penn, I., Fulginiti, V. A., Moon, J. B., Blanch-
ard, H., Martin, A. J. and Porter, K. A.: Orthotopic 
homotransplantation of the human liver. Ann. 
Surg., 1968, 168:392. 
3. von Kaulla, K. N., Kaye, H., von Kaulla, 
E., Marchioro, T. L. and Starzl, T. E.: Changes 
in blood coagulation before and after hepatec-
tomy or transplantation in dogs and man. Arch. 
Surg., 1966, 92:71. 
4. Groth, C. G., Pechet, L. and Starzl, T. E.: 
Coagulation during and after orthotopic trans-
plantation of the human liver. Arch. Surg., 1968 
(in press). 
5. Fonkalsrud, E. W.: Personal communication, 
February, 1968. 
6. Birtch, A.: Personal communication, August 
26, 1968. 
7. Starzl, T. E., Brettschneider, L., Penn, I., 
Schmidt, R. W., Bell, P., Kashiwagi, N., Town-
send, C. M. and Putnam, C. W.: A trial with 
heterologous antilymphocyte globulin in man. 
Transplantation Proceedings, New York, Grune 
and Stratton Inc., 1968. 
